Abratt RP, Brune D, Dimopoulos M-A, Kliment J, Breza J, Selvaggi FP, Beuzeboc P, Demkow T, Oudard S. Randomised phase III study of intravenous vinorelbine plus hormone therapy versus hormone therapy alone in hormone-refractory prostate cancer. Annals of Oncology [Internet]. 2004;15(11):1613 - 1621.